CanSino Biologics, Inc. Class H (6185) Income Statement

Last quarter (Q2 2025), CanSino Biologics, Inc. Class H's total revenue was ¥245.17M, an increase of 43.26% from the same quarter last year. In Q2, CanSino Biologics, Inc. Class H's net income was ¥-1.94M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.